You are not logged in.
Please login to continue selecting trials.
Generic NameBapineuzumabProduct NameTherapeutic AreaBehaviors and Mental DisordersEnrollment1121% Female55%% White95.8%
Product ClassMonoclonal AntibodySponsor Protocol NumberELN115727-302Data PartnerJohnson & JohnsonCondition StudiedAlzheimer DiseaseMean/Median Age (Years)72.2
- Collected Datasets Available
- Protocol with Amendments Available
- Statistical Analysis Plan Available
- Clinical Study Report Available
Approved Data Requests Associated with this Trial
- Proof-of-Concept study of a patient selection algorithm for disease modifying treatments in Alzheimer?s disease
- Optimizing Trial design to Achieve Personalized prevention of Alzheimer?s disease
- Getting new insight out of failed AD trials
- Reanalysis of Alzheimer?s Disease Clinical Trials Using Longitudinal Latent Trait Models
- Identification of biomarkers associated with Alzheimer?s disease progression that correlate with responses to medications.